Rapid update on childhood immune thrombocytopenic purpure.
Most childhood immune thrombocytopenic purpure is benign, self-limiting and requires no therapy. However, questions remain: (i) to treat or not; (ii) bone marrow examination or not; and (iii) admit to hospital or not. These questions have dominated the literature and we still need a prospective large multi-centre study of these issues to determine a useful bleeding score, quality of life measure and a measure of parental anxiety.
School of Paediatrics and Child Health, University of Western Australia, Haematology Laboratory, PathWest, and Department of Paediatric and Adolescent Haematology and Oncology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia. Catherine.Cole@health.wa.gov.au
Catherine H
CH
Cole
D000208:Acute Disease; D002648:Child; D002908:Chronic Disease; D004630:Emergencies; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy